Early Life and Education
George D. Yancopoulos, the son of Greek immigrants, was born in 1959. Growing up in Woodside, New York, he attended New York City public schools and showed exceptional academic abilities early on. He graduated as valedictorian of both the Bronx High School of Science, where he was also a top winner in the Westinghouse Science Talent Search in 1976, and Columbia College. Yancopoulos furthered his education at Columbia University's College of Physicians & Surgeons, earning his MD and PhD degrees in 1987.
Rise to Success
After completing his studies, Yancopoulos joined Regeneron Pharmaceuticals in 1989, shortly after its founding. He left academia to become a scientific founder of Regeneron Pharmaceuticals. Working alongside CEO Leonard Schleifer, Yancopoulos has played a pivotal role in transforming Regeneron into a leading biotechnology company. His scientific expertise and leadership have been crucial in the development of the company's innovative technologies and drug candidates. Yancopoulos has been recognized as the first research and development chief in the pharmaceutical industry to become a billionaire.
Key Business Strategies
Yancopoulos spearheaded the development of Regeneron's core technologies, including VelociGene and VelocImmune, which have significantly accelerated drug discovery. He also led the invention of multiple FDA-approved medicines, including Eylea, a treatment for age-related macular degeneration, and Dupixent. Regeneron's business strategy emphasizes in-house innovation and a deep understanding of disease biology, leading to the creation of a diverse portfolio of drugs. Strategic partnerships, such as the collaboration with Sanofi, have also been key to the company's growth.
Philanthropy
Yancopoulos is involved in Regeneron's STEM (Science, Technology, Engineering, and Math) Education commitments, including the Regeneron Science Talent Search.